Tiziana Life Sciences : Report Of Foreign Private Issuer - Form 6-K
Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple... | June 5, 2023
Source: marketscreener.com